Association between initial empirical therapy and decreased length of stay among veteran patients hospitalized with community acquired pneumonia

被引:15
作者
Lentino, JR [1 ]
Krasnicka, B
机构
[1] Edward Hines Jr VA Hosp, Cooperat Studies Program Coordinating Ctr, Med Serv, Sect Infect Dis 111P, Hines, IL 60141 USA
[2] Edward Hines Jr VA Hosp, Cooperat Studies Program Coordinating Ctr, Res Serv, Hines, IL 60141 USA
关键词
azithromycin; community acquired pneumonia (CAP); length of stay (LOS);
D O I
10.1016/S0924-8579(01)00472-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This investigation assessed the impact of initial empirical antimicrobial therapy on the outcome of therapy for community acquired pneumonia (CAP) patients and on patients' length of stay (LOS) in the hospital, Hospital records for 165 patients with pneumonia admitted to the Edward Hines, Jr. VA Hospital between 1 October 1997, and 31 March 2000, were reviewed. Criteria for CAP were met for 92 of 165 patients, Comparisons were made between patients treated with azithromycin and with other parenteral antibiotics (the reference group). No statistical differences were observed between the treatment groups for the risk factors. The azithromycin group patients were slightly older with a mean age of 69 years versus 66 years (P=0.23). Patients treated with parenteral azithromycin had on average, a shorter length of hospitalization namely 4.6 days compared with 9.7 days for patients treated with the other antibiotics (log-rank test, P=0.0001). In order to make the two groups of patients more alike we considered patients' data set without intensive care unit (ICU) admissions. The conclusion was the same namely azithromycin monotherapy was associated with a decreased duration of hospital stay. (C) 2002 Elsevier Science B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:61 / 66
页数:6
相关论文
共 35 条
  • [1] Agresti A., 1990, Analysis of categorical data
  • [2] COMMUNITY-ACQUIRED PNEUMONIA
    BARTLETT, JG
    MUNDY, LM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) : 1618 - 1624
  • [3] Community-acquired pneumonia in adults: Guidelines for management
    Bartlett, JG
    Breiman, RF
    Mandell, LA
    File, TM
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) : 811 - 838
  • [4] Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954
  • [5] Realizing the potential of clinical judgment: A real-time strategy for predicting outcomes and cost for medical inpatients
    Charlson, ME
    Hollenberg, JP
    Hou, J
    Cooper, M
    Pochapin, M
    Pecker, M
    [J]. AMERICAN JOURNAL OF MEDICINE, 2000, 109 (03) : 189 - 195
  • [6] Collett D, 2014, MODELLING SURVIVAL D
  • [7] A prognostic rule for elderly patients admitted with community-acquired pneumonia
    Conte, HA
    Chen, YT
    Mehal, W
    Scinto, JD
    Quagliarello, VJ
    [J]. AMERICAN JOURNAL OF MEDICINE, 1999, 106 (01) : 20 - 28
  • [8] Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995
    Doern, GV
    Heilmann, KP
    Huynh, HK
    Rhomberg, PR
    Coffman, SL
    Brueggemann, AB
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) : 1721 - 1729
  • [9] FINCH R, 1993, BRIT J HOSP MED, V49, P346
  • [10] Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia
    Fine, MJ
    Pratt, HM
    Obrosky, DS
    Lave, JR
    McIntosh, LJ
    Singer, DE
    Coley, CM
    Kapoor, WN
    [J]. AMERICAN JOURNAL OF MEDICINE, 2000, 109 (05) : 378 - 385